In the present study, we have demonstrated that SB-431542, a novel ALK5 receptor kinase inhibitor, inhibits tumour invasion and abrogated the pro-oncogenic functions of TGF-β including EMT and metastasis in both in vitro and in vivo models. Here, TGFB1 is linked to neoplasm.